Although leptin inhibits expression of orexigenic NPY/AgPR hypothalamic neurons, while stimulating anorexigenic POMC neurons in ARC (45), its practical therapeutical application in fighting excessive appetite in obese people appears to be unjustified because the majority of obese humans already exhibit high plasma levels of leptin, proportional to the body fat storage, indicating their resistance to circulating leptin (46)
Studies and research have indicated it is designed to target three hormone receptors (GLP-1, GIP, and glucagon), making it triple-action
More fragile than BPC-157, more sensitive than TB-500, more oxidation-prone than any GLP-1 analog
The Invisible Illness in Your Home: A Complete Guide to Mold Toxicity and Functional Recovery When Chronic Symptoms Have No Explanation, the Answer Might Be in Your Environment Youve seen the specialists
Clinical spectrum of succinic semialdehyde dehydrogenase deficiency